In this episode, Alireza Atri, MD, PhD, discusses his approach to patient conversations on brain health and provides advice to healthcare professionals practicing in community neurology settings, in a dialogue with Robin Martinez, a patient advocate from the Smart Patients online community. Supported by an educational grant from Lilly.

Faculty:

Alireza Atri, MD, PhD 
Chief Medical Officer, Banner Research
Phoenix, Tucson and Sun City, Arizona
Director, Banner Sun Health Research Institute
Sun City, Arizona

Robin Martinez
Patient Advocate
Coordinator of Online Communities
Website Administration
Smart Patients Inc.
Denver, Colorado

Resources mentioned in this episode:

• Alzheimer’s Association: DETeCD-ADRD Clinical Practice Guidelines for Specialty Care 
  https://bit.ly/4kqtYt5
• American Geriatrics Society: 2023 Beers Criteria for Potentially Inappropriate Medication Use in Older Adults 
  https://bit.ly/44zN8qG
• MoCA (Montreal Cognitive Assessment) : [Link to: https://mocacognition.com/]

Link to obtain CME/CE credit: 
https://bit.ly/44khuP5

Link to Brain Health Hub with additional educational activities:
https://bit.ly/4kziu6T

In this episode, dementia expert Anton Porsteinsson, MD, discusses his approach to conversations on brain health with patients and provides guidance for HCPs practicing in community psychiatry settings, in a dialogue with Robin Martinez, a patient advocate from the Smart Patients online community. Supported by an educational grant from Lilly.

Faculty:

Anton P. Porsteinsson, MD 
William B. and Sheila Konar Professor of Psychiatry, Neurology, Neuroscience, and Medicine
Director, Alzheimer’s Disease Care, Research and Education Program (AD-CARE)
University of Rochester School of Medicine and Dentistry
Rochester, New York

Robin Martinez
Patient Advocate
Coordinator of Online Communities
Website Administration
Smart Patients Inc.
Denver, Colorado

Resources mentioned in this episode:

• Mini Mental State Examination (MMSE) [Link to: https://www.psychdb.com/_media/mmse.]
• Mini-Cog (quick dementia screening test) [Link to: https://mini-cog.com/]
• MoCA (Montreal Cognitive Assessment) : [Link to: https://mocacognition.com/]
• Alzheimer’s Association Local Chapters [Link to:https://www.alz.org/chapter-search]
• Local Department of Aging [Link to : https://www.thecountyoffice.com/department-of-aging/]

Link to obtain CME/CE credit: 
https://bit.ly/3IAbyc7

Link to Brain Health Hub with additional educational activities: 
https://bit.ly/40Jgth4

In this episode, Genevieve Neal-Perry, MD, PhD, discusses her approach to conversations on brain health with her patients in obstetrics and gynecology settings, in a dialogue with Robin Martinez, a patient advocate from the Smart Patients online community. Supported by an educational grant from Lilly.

Faculty:

Genevieve Neal-Perry, MD, PhD 
Robert A. Ross Distinguished Professor
Chair of Obstetrics and Gynecology
University of North Carolina School of Medicine
Chapel Hill, North Carolina

Robin Martinez
Patient Advocate
Coordinator of Online Communities
Website Administration
Smart Patients Inc.
Denver, Colorado

Resources mentioned in this episode:

• Smart Patients, an online community for patients and their families [Link to: https://www.smartpatients.com/]

Link to obtain CME/CE credit: 
https://bit.ly/4lH4BEt

Link to Brain Health Hub with additional educational activities:
https://bit.ly/4nJrgSG

In this episode, Pierre N. Tariot, MD, discusses his approach to conversations on brain health with his patients and their family members in primary care settings, in a dialogue with Robin Martinez, a patient advocate from the Smart Patients online community. Supported by an educational grant from Lilly.

Faculty:
Pierre N. Tariot, MD
Director
Banner Alzheimer's Institute
Research Professor of Psychiatry
University of Arizona College of Medicine
Phoenix, Arizona

Robin Martinez
Patient Advocate
Coordinator of Online Communities
Website Administration
Smart Patients Inc.
Denver, Colorado

Resources mentioned in this episode:

• Banner Alzheimer Institute
• ECHO (Extension for Community Healthcare Outcomes)
• MoCA (Montreal Cognitive Assessment)
• Mini-Cog (quick dementia screening test)
• FDA Clears First Blood Test Used in Diagnosing Alzheimer’s Disease
• Lancet Commission: Dementia Prevention, Intervention, and Care 2024

Link to obtain CME/CE credit:
https://bit.ly/4kk1vFs

Link to Brain Health Hub with additional educational activities:
https://bit.ly/3H4hoSl

In this episode, Susan Scanland, MSN, CRNP, GNP-BC, CDP, discusses her approach to conversations on brain health with her patients and their family members in clinical practice as a gerontological nurse practitioner, in a dialogue with Robin Martinez, a patient advocate from the Smart Patients online community. Supported by an educational grant from Lilly.

Faculty:

• Susan Scanland, MSN, CRNP, GNP-BC, CDP
  CEO & Founder
  Dementia Connection LLC
  Clarks Summit, Pennsylvania
• Robin Martinez
  Patient Advocate
  Coordinator of Online Communities
  Website Administration
  Smart Patients Inc.
  Denver, Colorado

Resources mentioned in this episode:

• Alzheimer’s Association: 2025 Alzheimer’s Disease Facts and Figures
• Lancet Commission: Dementia Prevention, Intervention, and Care 2024
• American Geriatrics Society: 2023 Beers Criteria for Potentially Inappropriate Medication Use in Older Adults
• Alzheimer’s Association: DETeCD-ADRD Clinical Practice Guidelines for Primary Care
• Clinical Care Options: Integrating Brain Health Discussions Into Your Daily Routine

Link to obtain CME/CE credit:
https://bit.ly/4mqHoaS

Link to Brain Health Hub with additional educational activities:
https://bit.ly/3H4hoSl

Listen in as Cristina Mussini, MD; Martin Witzenrath, MD, FERS; and Michele Bartoletti, MD, PhD, discuss best practices in managing people who are immunocompromised with COVID-19 in the hospital setting, including: 

• COVID-19 burden among this population
• Initial workup to assess disease severity
• Summary of COVID-19 guideline recommendations
• A detailed patient case to illustrate key takeaways

Presenters:

Michele Bartoletti, MD, PhD​
Associate Professor of Infectious Diseases
Department of Biomedical Sciences
Humanitas University
Pieve Emanuele (MI), Italy
Head of Infectious Diseases Unit
IRCCS Humanitas Research Hospital
Rozzano (MI), Italy

Cristina Mussini, MD​
Full Professor of Infectious Diseases
Chief of the Department of Infectious Diseases
University of Modena and Reggio Emilia
Modena, Italy

Martin Witzenrath, MD, FERS
Medical Director
Charite Centrum 12
Internal Medicine & Dermatology
Professor and Chair for Respiratory Medicine and Critical Care
Department of Infectious Disease, Respiratory Medicine and Critical Care
Charite Campus Mitte/Campus Virchow Klinikum/Campus Benamin Franklin
Charite – University of Berlin
Berlin, Germany

Link to full program:
https://bit.ly/4fs7Hcb

Downloadable slides: 
https://bit.ly/4imCRU5

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

In this episode, Dr Robert Cotes and Dr David Goldsmith discuss their clinical experience with long-acting injectable antipsychotic treatments in the Grady Health System, with a focus on communication strategies to educate patients on their treatment options and engage them in shared decision-making.

Presenters: 

Robert O. Cotes, MD, DFAPA
Associate Professor and Distinguished Physician
Director, Clinical & Research Program for Psychosis at Grady Health System
Director, Project ARROW at Grady Health System
Department of Psychiatry and Behavioral Sciences
Emory University School of Medicine
Atlanta, Georgia

David R. Goldsmith, MD, MSc
Associate Professor
Director, Inflammation, Motivation, and Negative Symptoms of Schizophrenia (InMotioNSS) Lab
Co-Director, Clinical & Research Program for Psychosis at Grady Health System
Director, PSTAR Clinic at Grady Memorial Hospital
Faculty, Emory Behavioral Immunology Program
Co-Director, Psychiatry Residency Research Track
Department of Psychiatry and Behavioral Sciences
Emory University School of Medicine
Atlanta, Georgia

This content is part of an online CME program supported by educational grants from Indivior Inc.; Otsuka America Pharmaceutical, Inc. and Lundbeck; and Teva Pharmaceuticals. 

Link to full program: https://bit.ly/414XkY4

In this episode, David N. Lieberman, MD, PhD, and Eric Marsh, MD, PhD, discuss recent updates relevant to the treatment of Rett syndrome, including:

• The recently updated Comprehensive Care Guidelines from the International Rett Syndrome Foundation, available at rettsyndrome.org
• Ongoing collection and analysis of longitudinal data within the Rett Syndrome Natural History Study
• Efficacy and safety data from the double-blind, placebo-controlled phase III registrational LAVENDER trial evaluating oral trofinetide, a small molecule analogue of insulin-like growth factor 1
• Topline results from phase III AVATAR and EXCELLENCE trials of the sigma-1 receptor agonist blarcamesine
• Several early ongoing gene therapy trials

Dr Lieberman and Dr Marsh complement this informative update with wisdom from their own clinical experience to provide a full picture of current treatment and management options available to patients with Rett syndrome.

Presenters: 

David N. Lieberman, MD, PhD
Director, Comprehensive Rett Syndrome Clinic
Department of Neurology
Boston Children's Hospital
Boston, Massachusetts

Eric Marsh, MD PhD
Clinical Director, Orphan Disease Center
Director (MPI), CHOP/Penn IDDRC
Professor, Departments of Neurology and Pediatrics
Division of Neurology
Children’s Hospital of Philadelphia
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania

This content is part of an online CME program in partnership with the International Rett Syndrome Foundation and supported by an educational grant from Acadia Pharmaceuticals. Link to full program:
https://bit.ly/4fJRRL0

Link to CME: Claim Credit - https://bit.ly/3OByCaE

In this episode, Drs. Halford and Hahn discuss the current treatment landscape of developmental and epileptic encephalopathies (DEEs), such as Lennox-Gastaut syndrome and Dravet syndrome, and the emerging role of brain cholesterol in addressing seizure frequency. The full episode covers:

• How to diagnose these epilepsies and the FDA-approved treatment options in the first-line and second-line settings
• The role of antiseizure medications in DEE treatment management
• The nonpharmacological treatment options available to patients with DEEs
• The emerging role of brain cholesterol in neurologic diseases like DEEs and Alzheimer’s disease
• Results from the ELEKTRA clinical trial, including cholesterol synthase inhibitors’ impact on seizure frequency
• The future of soticlestat as a treatment option for pediatric patients with DEEs

Presenters:

Jonathan J. Halford, MD
Professor
Director, Translational Research Unit
Department of Neurology
Medical University of South Carolina
Charleston, SC

Cecil Hahn, MD, MPH, FRCPC
Professor
Pediatric Epileptologist
University of Toronto
Toronto, Ontario, Canada

Content based on an online CME program supported by an independent educational grant from Takeda Pharmaceuticals U.S.A., Inc.

Link to full program: 
https://bit.ly/45UUpQy

Link to CME: Claim Credit - https://bit.ly/3wbVkA1

In this episode, Drs. Halford and White discuss the emerging role of brain cholesterol in the development and potential treatment of neurological diseases like epilepsy or Alzheimer and Huntington diseases. The full episode covers:

• Overview of brain cholesterol and its function in the body
• Pathogenesis potential for certain diseases via brain cholesterol
• Emerging research on a cholesterol synthase inhibitor as a novel therapy
• The future of soticlestat as a potential treatment option for pediatric epilepsies—Lennox-Gastaut syndrome and Dravet syndrome—and other neurological diseases

Presenters:

Jonathan J. Halford, MD
Professor
Director, Translational Research Unit
Department of Neurology
Medical University of South Carolina
Charleston, SC

H. Steve White, PhD
Professor, Department of Pharmacy
Co-Director, Center for Epilepsy Drug Discovery
School of Pharmacy
University of Washington
Seattle, Washington